Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Smoking-related health beliefs and smoking behavior in the National Lung Screening Trial.

Kaufman AR, Dwyer LA, Land SR, Klein WMP, Park ER.

Addict Behav. 2018 Sep;84:27-32. doi: 10.1016/j.addbeh.2018.03.015. Epub 2018 Mar 14.

PMID:
29605757
2.

Cancer burden attributable to cigarette smoking among HIV-infected people in North America.

Altekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA.

AIDS. 2018 Feb 20;32(4):513-521. doi: 10.1097/QAD.0000000000001721.

PMID:
29239891
3.

Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.

Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS; ATS Assembly on Thoracic Oncology.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1202-1212. doi: 10.1164/rccm.201709-1858ST.

4.

Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01.

Kunitake H, Russell MM, Zheng P, Yothers G, Land SR, Petersen L, Fehrenbacher L, Giguere JK, Wickerham DL, Ko CY, Ganz PA.

J Cancer Surviv. 2017 Feb;11(1):111-118. doi: 10.1007/s11764-016-0567-y. Epub 2016 Aug 25.

5.

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research.

Land SR, Warren GW, Crafts JL, Hatsukami DK, Ostroff JS, Willis GB, Chollette VY, Mitchell SA, Folz JN, Gulley JL, Szabo E, Brandon TH, Duffy SA, Toll BA.

Cancer. 2016 Jun 1;122(11):1728-34. doi: 10.1002/cncr.29964. Epub 2016 Mar 28.

6.

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.

Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW.

Clin Cancer Res. 2016 Apr 15;22(8):1907-13. doi: 10.1158/1078-0432.CCR-16-0104. Epub 2016 Feb 17.

7.

Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.

Land SR, Walcott FL, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

J Natl Cancer Inst. 2015 Nov 27;108(4). pii: djv365. doi: 10.1093/jnci/djv365. Print 2016 Apr.

8.

Cancer screening and diagnosis: opportunities for smoking cessation intervention.

Land SR, Marcus PM.

J Clin Oncol. 2015 May 20;33(15):1631-2. doi: 10.1200/JCO.2015.61.2077. Epub 2015 Apr 20. No abstract available.

PMID:
25897157
9.

Comparison of media literacy and usual education to prevent tobacco use: a cluster-randomized trial.

Primack BA, Douglas EL, Land SR, Miller E, Fine MJ.

J Sch Health. 2014 Feb;84(2):106-15. doi: 10.1111/josh.12130.

10.

Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.

Land SR, Liu Q, Wickerham DL, Costantino JP, Ganz PA.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):823-32. doi: 10.1158/1055-9965.EPI-13-1105-T. Epub 2014 Feb 25.

11.

Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.

12.

CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.

Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL.

Subst Use Misuse. 2013 May;48(7):490-4. doi: 10.3109/10826084.2013.778280. Epub 2013 Mar 25.

13.

Associations of mental health problems with waterpipe tobacco and cigarette smoking among college students.

Primack BA, Land SR, Fan J, Kim KH, Rosen D.

Subst Use Misuse. 2013 Feb;48(3):211-9. doi: 10.3109/10826084.2012.750363. Epub 2013 Jan 10.

14.

Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.

Kopec JA, Colangelo LH, Land SR, Julian TB, Brown AM, Anderson SJ, Krag DN, Ashikaga T, Costatino JP, Wolmark N, Ganz PA.

J Support Oncol. 2013 Mar;11(1):22-30.

15.

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.

Stabile LP, Rothstein ME, Cunningham DE, Land SR, Dacic S, Keohavong P, Siegfried JM.

Carcinogenesis. 2012 Nov;33(11):2181-9. doi: 10.1093/carcin/bgs260. Epub 2012 Aug 2. Erratum in: Carcinogenesis. 2013 Jun;34(6):1411.

16.

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.

Kidwell KM, Yothers G, Ganz PA, Land SR, Ko CY, Cecchini RS, Kopec JA, Wolmark N.

Cancer. 2012 Nov 15;118(22):5614-22. doi: 10.1002/cncr.27593. Epub 2012 May 8.

17.

Methodologic barriers to addressing critical questions about tobacco and cancer prognosis.

Land SR.

J Clin Oncol. 2012 Jun 10;30(17):2030-2. doi: 10.1200/JCO.2012.41.7402. Epub 2012 May 7. No abstract available.

PMID:
22564998
18.

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

Allred DC, Anderson SJ, Paik S, Wickerham DL, Nagtegaal ID, Swain SM, Mamounas EP, Julian TB, Geyer CE Jr, Costantino JP, Land SR, Wolmark N.

J Clin Oncol. 2012 Apr 20;30(12):1268-73. doi: 10.1200/JCO.2010.34.0141. Epub 2012 Mar 5.

19.

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7.

20.

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400. doi: 10.1158/1940-6207.CAPR-11-0172. Epub 2011 Aug 23.

21.

An affective booster moderates the effect of gain- and loss-framed messages on behavioral intentions for colorectal cancer screening.

Ferrer RA, Klein WM, Zajac LE, Land SR, Ling BS.

J Behav Med. 2012 Aug;35(4):452-61. doi: 10.1007/s10865-011-9371-3. Epub 2011 Aug 18.

PMID:
21850516
22.

Adolescents' experiences using the contraceptive patch versus pills.

Sucato GS, Land SR, Murray PJ, Cecchini R, Gold MA.

J Pediatr Adolesc Gynecol. 2011 Aug;24(4):197-203. doi: 10.1016/j.jpag.2011.02.001. Epub 2011 Mar 30.

PMID:
21454110
23.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N.

J Natl Cancer Inst. 2011 Mar 16;103(6):478-88. doi: 10.1093/jnci/djr027. Epub 2011 Mar 11.

24.

Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice.

Stabile LP, Rothstein ME, Keohavong P, Lenzner D, Land SR, Gaither-Davis AL, Kim KJ, Kaminski N, Siegfried JM.

Cancers (Basel). 2010 Dec 1;2(4):2153-70. doi: 10.3390/cancers2042153.

25.

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.

Ganz PA, Land SR, Geyer CE Jr, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM.

J Clin Oncol. 2011 Mar 20;29(9):1110-6. doi: 10.1200/JCO.2010.29.7689. Epub 2011 Feb 7.

26.

Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01.

Kunitake H, Zheng P, Yothers G, Land SR, Fehrenbacher L, Giguere JK, Wickerham DL, Ganz PA, Ko CY.

J Clin Oncol. 2010 Dec 20;28(36):5274-9. doi: 10.1200/JCO.2010.30.1903. Epub 2010 Nov 15. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779. Wickerham, Lawrence [corrected to Wickerham, D Lawrence].

27.

Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.

Stabile LP, Dacic S, Land SR, Lenzner DE, Dhir R, Acquafondata M, Landreneau RJ, Grandis JR, Siegfried JM.

Clin Cancer Res. 2011 Jan 1;17(1):154-64. doi: 10.1158/1078-0432.CCR-10-0992. Epub 2010 Nov 9.

28.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP, Wolmark N, Ganz PA.

J Clin Oncol. 2010 Sep 1;28(25):3929-36. doi: 10.1200/JCO.2010.28.2491. Epub 2010 Aug 2. Erratum in: J Clin Oncol. 2010 Dec 20;28(36):5350.

29.

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N; National Surgical Adjuvant Breast, Bowel Project.

J Surg Oncol. 2010 Aug 1;102(2):111-8. doi: 10.1002/jso.21535.

30.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N.

N Engl J Med. 2010 Jun 3;362(22):2053-65. doi: 10.1056/NEJMoa0909638.

31.

Tobacco and cancer: an American Association for Cancer Research policy statement.

Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG; Writing Committee for the AACR Task Force on Tobacco and Cancer.

Cancer Res. 2010 May 1;70(9):3419-30. doi: 10.1158/0008-5472.CAN-10-1087. Epub 2010 Apr 13.

32.

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.

Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, Stolz DB, Land SR, Marconcini LA, Kliment CR, Jenkins KM, Beaulieu KA, Mouded M, Frank SJ, Wong KK, Shapiro SD.

Nat Med. 2010 Feb;16(2):219-23. doi: 10.1038/nm.2084. Epub 2010 Jan 17.

33.

Smoking behavior 1 year after computed tomography screening for lung cancer: Effect of physician referral for abnormal CT findings.

Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL.

Cancer Epidemiol Biomarkers Prev. 2009 Dec;18(12):3484-9. doi: 10.1158/1055-9965.EPI-09-0895.

34.

Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group.

Ganz PA, Land SR, Antonio C, Zheng P, Yothers G, Petersen L, Wickerham DL, Wolmark N, Ko CY.

J Cancer Surviv. 2009 Sep;3(3):137-47. doi: 10.1007/s11764-009-0093-2. Epub 2009 Jun 13.

35.

PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.

Fourcade J, Kudela P, Sun Z, Shen H, Land SR, Lenzner D, Guillaume P, Luescher IF, Sander C, Ferrone S, Kirkwood JM, Zarour HM.

J Immunol. 2009 May 1;182(9):5240-9. doi: 10.4049/jimmunol.0803245.

36.

Association between media use in adolescence and depression in young adulthood: a longitudinal study.

Primack BA, Swanier B, Georgiopoulos AM, Land SR, Fine MJ.

Arch Gen Psychiatry. 2009 Feb;66(2):181-8. doi: 10.1001/archgenpsychiatry.2008.532.

37.

Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells.

Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, Land SR, Srinivas H.

Mol Endocrinol. 2009 Feb;23(2):146-56. doi: 10.1210/me.2008-0431. Epub 2008 Dec 23. Erratum in: Mol Endocrinol. 2010 Feb;24(2):471.

38.

Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia.

Foon KA, Boyiadzis M, Land SR, Marks S, Raptis A, Pietragallo L, Meisner D, Laman A, Sulecki M, Butchko A, Schaefer P, Lenzer D, Tarhini A.

J Clin Oncol. 2009 Feb 1;27(4):498-503. doi: 10.1200/JCO.2008.17.2619. Epub 2008 Dec 15.

PMID:
19075274
39.

Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.

Jacobs SA, Swerdlow SH, Kant J, Foon KA, Jankowitz R, Land SR, DeMonaco N, Joyce J, Osborn JL, Evans TL, Schaefer PM, Luong TM.

Clin Cancer Res. 2008 Nov 1;14(21):7088-94. doi: 10.1158/1078-0432.CCR-08-0529.

40.

Missing patient-reported outcome data in an adjuvant lung cancer study.

Land SR.

J Clin Oncol. 2008 Nov 1;26(31):5018-9. doi: 10.1200/JCO.2008.18.2154. Epub 2008 Sep 22. No abstract available.

PMID:
18809601
41.

Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.

Fourcade J, Kudela P, Andrade Filho PA, Janjic B, Land SR, Sander C, Krieg A, Donnenberg A, Shen H, Kirkwood JM, Zarour HM.

J Immunother. 2008 Oct;31(8):781-91. doi: 10.1097/CJI.0b013e318183af0b.

42.

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Ganz PA, Land SR.

Menopause. 2008 Jul-Aug;15(4 Suppl):797-803. doi: 10.1097/gme.0b013e31817be9af. Review.

PMID:
18596601
43.

Statistics in oncology.

Land SR, Abrams J, Buyse M, Chappell RJ.

J Clin Oncol. 2008 Aug 1;26(22):3668. doi: 10.1200/JCO.2008.18.5900. No abstract available.

PMID:
18669450
44.

Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.

Stabile LP, Rothstein ME, Keohavong P, Jin J, Yin J, Land SR, Dacic S, Luong TM, Kim KJ, Dulak AM, Siegfried JM.

Mol Cancer Ther. 2008 Jul;7(7):1913-22. doi: 10.1158/1535-7163.MCT-07-2169.

45.

The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.

Styn MA, Nukui T, Romkes M, Perkins K, Land SR, Weissfeld JL.

Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):254-61. doi: 10.1002/ajmg.b.30801.

46.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
47.

Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.

Wang W, Edington HD, Jukic DM, Rao UN, Land SR, Kirkwood JM.

Cancer Immunol Immunother. 2008 Sep;57(9):1315-21. doi: 10.1007/s00262-008-0466-9. Epub 2008 Apr 3.

PMID:
18386001
48.

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

Mamounas EP, Jeong JH, Wickerham DL, Smith RE, Ganz PA, Land SR, Eisen A, Fehrenbacher L, Farrar WB, Atkins JN, Pajon ER, Vogel VG, Kroener JF, Hutchins LF, Robidoux A, Hoehn JL, Ingle JN, Geyer CE Jr, Costantino JP, Wolmark N.

J Clin Oncol. 2008 Apr 20;26(12):1965-71. doi: 10.1200/JCO.2007.14.0228. Epub 2008 Mar 10.

PMID:
18332472
49.

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

Swain SM, Land SR, Ritter MW, Costantino JP, Cecchini RS, Mamounas EP, Wolmark N, Ganz PA.

Breast Cancer Res Treat. 2009 Jan;113(2):315-20. doi: 10.1007/s10549-008-9937-0. Epub 2008 Feb 27.

50.

Adolescent smoking and volume of exposure to various forms of media.

Primack BA, Land SR, Fine MJ.

Public Health. 2008 Apr;122(4):379-89. doi: 10.1016/j.puhe.2007.07.022. Epub 2008 Feb 21.

Supplemental Content

Support Center